SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ (LAES) is trending due to a strategic partnership to develop 'Made in US' post-quantum cryptography solutions for US government and defense, sparking bullish sentiment. The community is actively discussing the potential for a short squeeze and significant upside, drawing comparisons to other quantum stocks. With high trading volume and positive news, investors are optimistic about the company's future growth and potential double-digit price targets.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending as investors anticipate upcoming earnings and potential hyperscaler announcements, crucial for the company's AI infrastructure growth. Community discussions revolve around the timing of a new lease and the impact of Macquarie's recent funding draw. Bullish sentiment remains high due to the expected increase in AI data center demand and APLD's strategic position.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending due to recent AI partnerships, sparking investor excitement about its potential in the agentic AI space; some view it as undervalued compared to competitors like $PLTR. The community is discussing its strategic shift from RPA to AI-driven automation and whether it can sustain growth, while others are eyeing potential short squeezes.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending as gold prices surge to new all-time highs, driven by safe-haven demand amid economic uncertainty and geopolitical tensions, potentially signaling a broader market correction. Community members are actively debating whether this rally is sustainable, with some pointing to overbought conditions while others anticipate further gains due to ongoing global instability and central bank activity. Discussions also revolve around the relationship between gold, the dollar, and other asset classes like equities and crypto.

Global Health Solutions Inc is an American company that works with partners to eliminate diseases that have plagued humanity for centuries and protect the health of populations by helping countries build strong health systems. The private company is located in the US. The company brings together key stakeholders around the world with a common goal to stop diseases and strengthen health systems through powerful partnerships. The company consists of programs and focus areas that cover a range of health issues including neglected tropical diseases, infectious diseases, vaccines, field epidemiology, public health informatics, health workforce development, and health ethics. The company's end goal is to eliminate diseases and protect the health of populations.

Turn Therapeutics Inc.

Turn Therapeutics Inc

Turn Therapeutics ($TTRX) is trending due to significant price volatility following its recent IPO, with the community actively debating potential short squeezes and bag holding scenarios. Discussions revolve around the stock's rapid price fluctuations and whether it represents a genuine opportunity or a classic pump-and-dump scheme. The stock's performance is also drawing comparisons to other recent high-flying biotech stocks.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense & Security Solutions is trending amid discussions about defense spending, potential contract wins, and comparisons to other high-growth tech and defense companies. The community is actively debating its valuation, potential for acquisitions, and upcoming catalysts like government contracts and drone technology advancements. Some traders are taking profits after a significant run-up, while others see it as a long-term growth play.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge, nearing multi-decade highs, fueled by potential for a short squeeze and discussions of a 45-year cup and handle formation. Community chatter revolves around big banks potentially manipulating the price and excitement about silver's potential to reach new all-time highs. Some investors are adding to their positions, while others are taking profits or expressing concerns about a possible pullback.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

SERV is trending due to its expanding partnerships in the autonomous delivery space, particularly with DoorDash, sparking discussions about the company's growth potential and market dominance. Community members are actively discussing the high call option volume, potential for a short squeeze, and the long-term prospects of robotic food delivery. Despite some concerns about high operating costs, the stock is seeing increased attention as a strong relative strength name in the robotics sector.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy ($ENPH) is trending as the stock shows signs of bouncing back, prompting discussions about a potential breakout and short squeeze. Community members are actively debating whether the stock has hit its rock bottom and if it's poised for a significant upward move, while also noting positive momentum in the broader solar sector. Some analysts point to potential benefits from future interest rate cuts, even amidst concerns about policy headwinds.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings ($ARM) is trending amid discussions about its valuation and future growth prospects, with community members debating whether the stock is overvalued despite its strong position in AI and mobile chip design. Some investors believe the recent dip presents a buying opportunity, while others express concerns about competition and execution risks, particularly following earnings. Intel's manufacturing capabilities could capture part of that business, reducing TSM’s future revenue streams as Nvidia diversifies its supply chain. 

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jagsonpal Pharmaceuticals, a healthcare company focused on gynecology, dermatology, pediatrics, and orthopedics, has seen a stellar run in the last five sessions,, with its shares rallying 11%. However, the stock is facing stiff resistance between ₹300 and ₹320.On Tuesday, <a href="https://stocktwits.com/symbol/JAGSNPHARM.NSE">Jagsonpal Pharma shares</a> faced rejection near ₹298 - ₹300, an area which has historically acted as a strong supply zone, marked by sharp sell-offs and distribution, noted SEBI-registered <a href="https://stocktwits.com/VijayGuptaAdvisory">analyst Vijay Kumar Gupta</a>.However, the overall structure remains bullish with a series of higher highs and higher lows, Gupta said.<stembedurl>https://stocktwits.com/VijayGuptaAdvisory/message/622812109</stembedurl>For a sustained move higher, a daily close above ₹320, supported by volume, would confirm a breakout and potentially open the path to fresh upside levels. Until then, price action in this resistance band should be watched closely for signs of reversal or consolidation, the analyst added.On the downside, immediate support lies in the ₹250 - ₹260 range, which has previously acted as a breakout base. The analyst believes that the first support should act as an ideal re-entry zone for aggressive swing traders.Further support is seen at ₹200 - ₹225, a historically strong bullish order block, and at ₹140–₹160, a long-term accumulation zone aligned with past earnings reactions.While the bullish trend is intact, Jagsonpal faces a crucial resistance hurdle. Failure to hold above ₹275 may shift the trend to sideways or weaken short-term momentum, he added.Retail sentiment on Stocktwits slid to ‘bullish’ from ‘extremely bullish’ a day earlier.<figure class="image"><img style="aspect-ratio:916/79;" src="https://news.stocktwits-cdn.com/Jagsonpal_png_81f0b5a38d.webp" alt="Jagsonpal.png" width="916" height="79"><figcaption><span style="background-color:rgb(255,255,255);color:rgb(50,50,77);font-family:-apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, Oxygen, Ubuntu, Cantarell, &quot;Open Sans&quot;, &quot;Helvetica Neue&quot;, sans-serif;">JAGSNPHARM's Sentiment Meter and Message Volumes at 09:14 a.m. IST on July 30 | Source: Stocktwits</figcaption></figure>The closed marginally higher at ₹287.99 on Tuesday, having lost more than 55% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com

Red candles of the American S&P 500 index are seen in a chart on Trading View on the monitor of a computer in an office. Photo: Silas Stein/ (Photo by Silas Stein/picture alliance via Getty Images)

Jagsonpal Pharma’s Rally Faces Litmus Test At ₹320; SEBI RA Vijay Gupta Cautions Supply Zone May Stall Momentum

On the downside, immediate support lies in the ₹250 - ₹260 range, which has previously acted as a breakout base. The analyst recommends re-entry at this point. 

Equity

Two SEBI-registered analysts have highlighted four stocks that show promising technical setups and volume action.While Financial Sarthis is bullish on Jagsonpal Pharmaceuticals and Alkem Laboratories, analyst Kavita Agrawal has picked Senores Pharma and Cummins India as ideal opportunities.&nbsp;Let’s take a closer look at why these stocks are worth adding to your watchlist.Analyst&nbsp;<a href="https://stocktwits.com/financialsarthis">Financial Sarthis</a> has flagged two pharma stocks to add to the stock watchlist.Jagsonpal Pharmaceuticals<a href="https://stocktwits.com/symbol/JAGSNPHARM.NSE">Jagson Pharma</a> recently pulled off a horizontal breakout above ₹279.45. The massive volume spike indicates that smart money is entering the stock. They have identified the next target at ₹325 and higher.&nbsp;Alkem Laboratories<a href="https://stocktwits.com/symbol/ALKEM.NSE">Alkem</a> has formed a base consolidation. Watch for a breakout above ₹5,075, with support at ₹4,930. Volumes have seen a gradual build-up, but no explosive volume yet.&nbsp;He added that the stock is testing a key horizontal resistance at ₹5,050. A breakout above this zone, supported by volume, could open up a rally toward ₹5,250–5,400.<stembedurl>https://stocktwits.com/financialsarthis/message/622673870</stembedurl>Meanwhile, analyst&nbsp;<a href="https://stocktwits.com/KavitaAgrawalCMTCFA">Kavita Agrawal</a> has identified Senores Pharma and Cummins for significant upside potential ahead.Senores PharmaceuticalOn its daily chart, Agrawal observed a strong breakout on high volumes supported by a healthy pullback and low volumes, which is considered a bullish sign.&nbsp;&nbsp;She added that the current setup in&nbsp;<a href="https://stocktwits.com/symbol/SENORES.NSE">Senores</a> looks attractive with the trendline support holding well. According to her, this pullback presents a great entry opportunity with an immediate target of ₹834, accompanied by a stop-loss below ₹600.<stembedurl>https://stocktwits.com/KavitaAgrawalCMTCFA/message/622700109</stembedurl>Cummins IndiaHer other recommendation is&nbsp;<a href="https://stocktwits.com/symbol/CUMMINSIND.NSE">Cummins India</a>. Momentum is strong across the board, and volume picked up during the upward move.&nbsp;She added that the stock has now reached that recharge zone, making this a buy-on-dip opportunity. Agrawal identified an ideal entry around ₹3,450, with a suggested stop loss at ₹3,325 for a potential target of ₹3,891.<stembedurl>https://stocktwits.com/KavitaAgrawalCMTCFA/message/622700291</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Momentum Trade Ideas: SEBI RAs See Breakout Opportunities In These Pharma And Industrial Stocks

Analysts have highlighted Jagsonpal, Alkem, Senores Pharma, and Cummins India as strong near-term opportunities based on technical setups and volume action

Analysts have highlighted Jagsonpal, Alkem, Senores Pharma, and Cummins India as strong near-term opportunities based on technical setups and volume action.

7 Indian stocks that align with Peter Lynch's growth investing strategy

Seven Indian stocks—Jagsonpal Pharmaceuticals, Sandur Manganese & Iron Ore, G M Breweries, Indian Metal & Ferro Alloys, VST Industries, Maithan Alloys, and D-Link—align with Peter Lynch's growth investing strategy, highlighting their operating revenues, annual revenue growth, profitability margins, and strong balance sheets. These stocks are identified by MarketSmith based on Lynch’s methodology.

Jagsonpal Pharmaceuticals Ltd. engages in the development and manufacture of intermediate drugs and pharmaceutical formulations. It offers portfolio of drugs focusing on the gynaecology, dermatology, paediatric, and orthopaedic segments. The company was founded by Jagmohan Singh Kochhar on August 17, 1978 and is headquartered in Gurugram, India.

JAGSNPHARM.NSE
Jagsonpal Pharmaceuticals Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest JAGSNPHARM.NSE News

JAGSNPHARM.NSE Jagsonpal Pharmaceuticals Ltd.